ADARA ABDALAH: Open Payments
NPI 1295321412 · DAVIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 56 payments from 15 companies in 2025. Trend: 2023 $381 · 2024 $470 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $512 |
| ABBVIE INC. | 8 | $186 |
| Corium, LLC | 6 | $119 |
| Axsome Therapeutics, Inc. | 4 | $100 |
| Alkermes, Inc. | 5 | $88 |
| Lundbeck LLC | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Almatica Pharma LLC | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: CAPLYTA, VRAYLAR, Azstarys, Auvelity, REXULTI, TRINTELLIX, ARISTADA, LYBALVI.
Industry payments across FL — which companies pay providers there.
